MedPath

Acute Effects of an Herbal Tea on Immune Surveillance and Activation.

Not Applicable
Completed
Conditions
Active Immune Response
Registration Number
NCT04491461
Lead Sponsor
Natural Immune Systems Inc
Brief Summary

A small cross-over trial on 24 people involving an herbal tea blend to test whether consuming 1 cup of tea triggers changes in the numbers of natural killer cells in the blood circulation as evidence of immune cell trafficking within 2 hours.

Detailed Description

A randomized, cross-over, controlled study design will be used to evaluate the effects of consumption of 1 cup of an herbal tea blend to consumption of the same volume of warm water. The study is of 3 weeks' duration, with evaluation of the herbal tea blend versus warm water at week 1 and week 2 with a one week washout between visits. On each visit, a baseline blood draw is performed, followed by consuming of the herbal tea blend or warm water. Blood draws are performed at 1 and 2 hours after consumption.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Healthy adults;
  • Age 18-75 years (inclusive);
  • Veins easy to see in both arms (to allow for the multiple blood draws);
  • Willing to comply with a 24-hour wash-out period for vitamins and nutritional supplements;
Exclusion Criteria
  • Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder);
  • Taking anti-inflammatory medications on a daily basis;
  • Currently experiencing intense stressful events/ life changes;
  • Currently in intensive athletic training (such as marathon runners);
  • Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel;
  • Actively depressed;
  • An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
  • Unwilling to maintain a constant intake of supplements over the duration of the study;
  • Anxiety about having blood drawn;
  • Women of childbearing potential: Pregnant, nursing, or trying to become pregnant;
  • Known food allergies related to ingredients in active test product.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change to natural killer cell numbers in blood circulationChanges at 1 and 2 hours after consumption

Flow cytometry evaluation of natural killer cell numbers

Secondary Outcome Measures
NameTimeMethod
Change to natural killer cell activation statusChanges at 1 and 2 hours after consumption

Flow cytometry evaluation of CD69 expression on natural killer cells in the blood circulation

Trial Locations

Locations (1)

Gitte Jensen

🇺🇸

Klamath Falls, Oregon, United States

Gitte Jensen
🇺🇸Klamath Falls, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.